Article 32SDB Investigational MERS vaccine receives approval for Phase I trial in South Korea

Investigational MERS vaccine receives approval for Phase I trial in South Korea

by
Press Release
from Outbreak News Today on (#32SDB)

GeneOne Life Science, Inc. announces that it has received approval from the South Korean Ministry of Food and Drug Safety (KMFDS) for an Investigational New Drug application for a Phase I/IIa study of its investigational vaccine, GLS-5300, against the Middle East Respiratory Syndrome coronavirus (MERS-CoV). The study in Korea represents the second clinical trial for ["]

The post Investigational MERS vaccine receives approval for Phase I trial in South Korea appeared first on Outbreak News Today.

OutbreakNewsToday?d=yIl2AUoC8zA OutbreakNewsToday?d=qj6IDK7rITs OutbreakNewsToday?d=63t7Ie-LG7Y
External Content
Source RSS or Atom Feed
Feed Location http://feeds.feedburner.com/OutbreakNewsToday
Feed Title Outbreak News Today
Feed Link https://outbreaknewstoday.com/
Feed Copyright The Global Dispatch, Inc
Reply 0 comments